Does OFATUMUMAB Cause Injection site bruising? 532 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 532 reports of Injection site bruising have been filed in association with OFATUMUMAB (ARZERRA). This represents 1.8% of all adverse event reports for OFATUMUMAB.
532
Reports of Injection site bruising with OFATUMUMAB
1.8%
of all OFATUMUMAB reports
0
Deaths
18
Hospitalizations
How Dangerous Is Injection site bruising From OFATUMUMAB?
Of the 532 reports, 18 (3.4%) required hospitalization, and 2 (0.4%) were considered life-threatening.
Is Injection site bruising Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OFATUMUMAB. However, 532 reports have been filed with the FAERS database.
What Other Side Effects Does OFATUMUMAB Cause?
Fatigue (5,202)
Headache (4,430)
Pain (3,382)
Chills (3,372)
Pyrexia (3,370)
Influenza like illness (2,727)
Nausea (1,688)
Multiple sclerosis relapse (1,525)
Covid-19 (1,435)
Asthenia (1,393)
What Other Drugs Cause Injection site bruising?
ETANERCEPT (7,734)
ADALIMUMAB (7,249)
EVOLOCUMAB (4,409)
TERIPARATIDE (4,405)
DUPILUMAB (4,332)
TIRZEPATIDE (2,665)
SECUKINUMAB (1,969)
DULAGLUTIDE (1,832)
HUMIRA (1,623)
EXENATIDE (1,299)
Which OFATUMUMAB Alternatives Have Lower Injection site bruising Risk?
OFATUMUMAB vs OFLOXACIN
OFATUMUMAB vs OLANZAPINE
OFATUMUMAB vs OLANZAPINE\SAMIDORPHAN L-MALATE
OFATUMUMAB vs OLAPARIB
OFATUMUMAB vs OLARATUMAB